Envestnet Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,892
| Closed | -$39.6K | – | 4198 |
|
|
2023
Q4 | $39.6K | Sell |
11,892
-10,258
| -46% | -$34.2K | ﹤0.01% | 3995 |
|
|
2023
Q3 | $82.8K | Buy |
22,150
+5,857
| +36% | +$21.9K | ﹤0.01% | 3895 |
|
|
2023
Q2 | $69.6K | Sell |
16,293
-840
| -5% | -$3.59K | ﹤0.01% | 3856 |
|
|
2023
Q1 | $117K | Buy |
17,133
+1,154
| +7% | +$7.89K | ﹤0.01% | 3775 |
|
|
2022
Q4 | $127K | Sell |
15,979
-8,212
| -34% | -$65K | ﹤0.01% | 3769 |
|
|
2022
Q3 | $232K | Buy |
24,191
+6,345
| +36% | +$60.9K | ﹤0.01% | 3506 |
|
|
2022
Q2 | $129K | Sell |
17,846
-1,122
| -6% | -$8.11K | ﹤0.01% | 3721 |
|
|
2022
Q1 | $245K | Sell |
18,968
-7,221
| -28% | -$93.3K | ﹤0.01% | 3562 |
|
|
2021
Q4 | $418K | Buy |
26,189
+3,136
| +14% | +$50.1K | ﹤0.01% | 3186 |
|
|
2021
Q3 | $370K | Buy |
23,053
+2,346
| +11% | +$37.7K | ﹤0.01% | 3162 |
|
|
2021
Q2 | $286K | Buy |
20,707
+257
| +1% | +$3.55K | ﹤0.01% | 3314 |
|
|
2021
Q1 | $299K | Sell |
20,450
-173
| -0.8% | -$2.53K | ﹤0.01% | 3133 |
|
|
2020
Q4 | $358K | Buy |
20,623
+6,884
| +50% | +$120K | ﹤0.01% | 2832 |
|
|
2020
Q3 | $252K | Sell |
13,739
-496
| -3% | -$9.1K | ﹤0.01% | 2808 |
|
|
2020
Q2 | $254K | Sell |
14,235
-35,742
| -72% | -$638K | ﹤0.01% | 2764 |
|
|
2020
Q1 | $811K | Buy |
49,977
+4,798
| +11% | +$77.9K | ﹤0.01% | 1943 |
|
|
2019
Q4 | $813K | Buy |
45,179
+2,476
| +6% | +$44.6K | ﹤0.01% | 2159 |
|
|
2019
Q3 | $865K | Buy |
+42,703
| New | +$865K | ﹤0.01% | 2043 |
|
|
2018
Q3 | – | Sell |
-1,261
| Closed | -$18K | – | 1469 |
|
|
2018
Q2 | $18K | Buy |
1,261
+209
| +20% | +$2.98K | ﹤0.01% | 2442 |
|
|
2018
Q1 | $12K | Buy |
1,052
+516
| +96% | +$5.89K | ﹤0.01% | 2461 |
|
|
2017
Q4 | $5K | Buy |
+536
| New | +$5K | ﹤0.01% | 2735 |
|